News

AddToAny

Google+ Facebook Twitter Twitter

“Superbug spreading undetected”

A superbug resistant to all known antibiotics is spreading undetected through hospital wards across the world, it is claimed.

Researchers at the University of Melbourne discovered three variants of the multidrug-resistant bug in samples from 10 countries, including strains in Europe that cannot be reliably tamed by any drug currently on the market.

Ben Howden, Director of the university’s Microbiological Diagnostic Unit Public Health Laboratory, said: “We started with samples in Australia but did a global snapshot and found that it’s in many countries and many institutions around the world. It seems to have spread.”

The bacteria, known as “Staphylococcus epidermidis”, is related to the better-known and more deadly MRSA. It’s found naturally on human skin and most commonly infects the elderly, or patients who have had prosthetic materials implanted, such as catheters and joint replacements.

The team looked at hundreds of S. epidermidis specimens from 78 hospitals worldwide. They found some strains of the bug made small DNA changes that led to resistance to the most common antibiotics.

 

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top